These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 14631136)

  • 21. Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study.
    Gerbaud E; Montaudon M; Chasseriaud W; Gilbert S; Cochet H; Pucheu Y; Horovitz A; Bonnet J; Douard H; Coste P
    Arch Cardiovasc Dis; 2014 Jan; 107(1):33-41. PubMed ID: 24440004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of a pure reduction in heart rate for the treatment of left ventricular dysfunction: clinical benefits of ivabradine in the BEAUTIFUL trial.
    Danchin N
    Therapie; 2009; 64(2):111-4. PubMed ID: 19664404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart rate reduction by I(f)-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction.
    Reil JC; Reil GH; Böhm M
    Trends Cardiovasc Med; 2009 Jul; 19(5):152-7. PubMed ID: 20005474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.
    Bruguera Cortada J; Varela A
    Am J Cardiovasc Drugs; 2009; 9 Suppl 1():9-12. PubMed ID: 20000882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
    Paraskevaidis I; Farmakis D; Parissis JT; Dodouras T; Filippatos G; Tsiapras D; Kremastinos DT
    J Card Fail; 2007 Mar; 13(2):108-13. PubMed ID: 17395050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.
    Tardif JC; O'Meara E; Komajda M; Böhm M; Borer JS; Ford I; Tavazzi L; Swedberg K;
    Eur Heart J; 2011 Oct; 32(20):2507-15. PubMed ID: 21875858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure (from the SHIFT study).
    Borer JS; Böhm M; Ford I; Robertson M; Komajda M; Tavazzi L; Swedberg K;
    Am J Cardiol; 2014 Feb; 113(3):497-503. PubMed ID: 24332674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart rate reduction induced by the if current inhibitor ivabradine improves diastolic function and attenuates cardiac tissue hypoxia.
    Fang Y; Debunne M; Vercauteren M; Brakenhielm E; Richard V; Lallemand F; Henry JP; Mulder P; Thuillez C
    J Cardiovasc Pharmacol; 2012 Mar; 59(3):260-7. PubMed ID: 22075752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure.
    De Ferrari GM; Mazzuero A; Agnesina L; Bertoletti A; Lettino M; Campana C; Schwartz PJ; Tavazzi L
    Eur J Heart Fail; 2008 Jun; 10(6):550-5. PubMed ID: 18486549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ivabradine on heart rate and left ventricular function in healthy cats and cats with hypertrophic cardiomyopathy.
    Riesen SC; Schober KE; Smith DN; Otoni CC; Li X; Bonagura JD
    Am J Vet Res; 2012 Feb; 73(2):202-12. PubMed ID: 22280379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ivabradine: heart rate and left ventricular function.
    Ferrari R
    Cardiology; 2014; 128(2):226-30. PubMed ID: 24776521
    [No Abstract]   [Full Text] [Related]  

  • 32. Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT.
    Böhm M; Komajda M; Borer JS; Ford I; Maack C; Tavazzi L; Moyne A; Swedberg K;
    Eur J Heart Fail; 2018 Feb; 20(2):373-381. PubMed ID: 29027329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effects of ivabradine and atenolol on heart rate and echocardiographic variables of left heart function in healthy cats.
    Riesen SC; Schober KE; Cervenec RM; Bonagura JD
    J Vet Intern Med; 2011; 25(3):469-76. PubMed ID: 21418320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PDE 5 inhibition with udenafil improves left ventricular systolic/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; A 12-week, randomized, double-blind, placebo-controlled trial.
    Kim KH; Kim HK; Hwang IC; Cho HJ; Je N; Kwon OM; Choi SJ; Lee SP; Kim YJ; Sohn DW
    Am Heart J; 2015 Jun; 169(6):813-822.e3. PubMed ID: 26027619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained-Release Ivabradine Hemisulfate in Patients With Systolic Heart Failure.
    Ye F; Wang X; Wu S; Ma S; Zhang Y; Liu G; Liu K; Yang Z; Pang X; Xue L; Lu S; Zhong M; Li J; Yu H; Lou D; Cui D; Xie X; Wang J;
    J Am Coll Cardiol; 2022 Aug; 80(6):584-594. PubMed ID: 35926931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of inter- and intraventricular asynchrony by tissue Doppler echocardiography].
    Faber L; Lamp B; Hering D; Bogunovic N; Scholtz W; Heintze J; Vogt J; Horstkotte D
    Z Kardiol; 2003 Dec; 92(12):994-1002. PubMed ID: 14663609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ivabradine improves left ventricular twist and untwist during chronic hypertension.
    Jozwiak M; Melka J; Rienzo M; Bizé A; Sambin L; Hittinger L; Berdeaux A; Su JB; Bouhemad B; Ghaleh B
    Int J Cardiol; 2018 Feb; 252():175-180. PubMed ID: 29196088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and β-receptor blockade.
    Becher PM; Lindner D; Miteva K; Savvatis K; Zietsch C; Schmack B; Van Linthout S; Westermann D; Schultheiss HP; Tschöpe C
    Hypertension; 2012 May; 59(5):949-57. PubMed ID: 22493071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correction of sinus rate by inhibitors of If-channels in patients with acute decompensated heart failure].
    Saĭganov SA; Karchik'ian PO
    Kardiologiia; 2014; 54(11):34-8. PubMed ID: 25902657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.